View printer-friendly version Amgen Reports First Quarter 2017 Financial Results BUZ INVESTORS  PRESS RELEASE  Amgen Reports First Quarter Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2017. Key results include: Total revenues decreased 1 percent versus the first quarter of 2016 to $5.5 billion. GAAP earnings per share (EPS) increased 12 percent to
Complete Reading

Amgen Stock – the Best Biotech Stock 2017? Buz Investors Best Biotech Stock 2017  The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors. With so much depending on government regulation, competition, and public opinion, there’s a lot of room to make big gains in the biotech industry, and a lot
Complete Reading

Amgen, Inc.: This Is Why AMGN Stock is Going Nuts Today Buz Investors AMGN Stock is Going Nuts  Equities were hammered on Wednesday following news that Donald Trump won the U.S. presidency, but shares of Amgen, Inc. (NASDAQ:AMGN) stock are bucking that trend. At the opening bell, shares of AMGN stock surged to $150.74, up
Complete Reading

Create Account



Log In Your Account



Dash_En